Quality

known as Thrombolysis, is a treatment to dissolve dangerous clots in blood vessels, improve blood flow, and prevent damage to tissues and organs. Thrombolysis may involve the injection of clot-busting drugs through an intravenous (IV) line or through a long catheter that delivers drugs directly to the site of the blockage. Thrombolysis is often used as an emergency treatment to dissolve blood clots that form in arteries feeding the heart and brain.

Transcutaneous pacing is initiated as a temporary short-term measure when there has been a failure of the normal conduction of the heart to produce an electrical impulse resulting in a hemodynamic compromise in the

What is lntra-Aortic Balloon Pump Therapy – It is a short-term cardiac assist device placed in the descending aorta to improve myocardial oxygen supply and reduce […]

Most Responsible Physician (MRP): Most Responsible Physician is the Admitting Physician who is responsible for the overall care rendered to the patient and accountable for the […]

Informed Consent — agreement or permission accompanied by full information on the nature, risks, and alternatives of a medical procedure or treatment. Comgetent Individual – A […]

Combined management: Combined management is a comprehensive care, with the involvement of more than one specialty for the patients requiring complex care. Patient will be admitted under the Most Responsible Physician who will be able to provide the maximum care to the most significant presenting symptoms of the patient.

Ischemic chest pain of at least 15 minutes duration, and unrelieved with sublingual nitroglycerine (2 times). ECG evidence of Acute Myocardial Infarction (1- 2 mm ST segment elevation in two contiguous leads or new onset of complete left bundle branch block. Thrombolytic therapy should be given within 12 hours (preferably < 4 hours) of onset of chest pain that is consistent with myocardial infarction .In case of recurrence or persistence  of chest pain the period can be extended to 24 hours.

Venous thromboembolism (VTE) is a disease includes deep venous thrombosis (DVT) and pulmonary embolism (PE) and is a significant potential health complication for hospitalised patients. Serious adverse outcomes may occur, including an increased risk of recurrent thrombosis, morbidity from post thrombotic syndrome or death.